NEOVEIL NV-L-015G

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-07-05 for NEOVEIL NV-L-015G manufactured by Gunze Limited.

Event Text Entries

[113264333] Name of the adverse event: anaphylactic shock. Resected right middle lobe of lung to lung cancer in right middle lobe. Applied neoveil and fibrin glue("bolheal" kaketsuken) to pulmonary fistula part to deal with pulmonary fistula. After that, rash appeared on neck, trunk and limbs. Additionally, the blood pressure decreased rapidly. Above symptoms are observed during the chest closure, so opened the chest promptly, removed neoveil and fibrin glue as much as possible, and the thoracic cavity was washed. After that, chest closure was performed. The patient pulled out the drain on 9th postoperative day and was discharged 2 weeks after the operation. The doctor judged that the anaphylactic reaction was recovering.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007958945-2018-00001
MDR Report Key7664577
Date Received2018-07-05
Date of Report2018-06-04
Date of Event2018-05-09
Date Facility Aware2018-06-04
Report Date2018-06-21
Date Reported to FDA2018-06-21
Date Reported to Mfgr2018-06-04
Date Added to Maude2018-07-05
Event Key0
Report Source CodeDistributor report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEOVEIL
Generic NameSTAPLE LINE REINFORCEMENT MATERIAL
Product CodeOXC
Date Received2018-07-05
Model NumberNV-L-015G
Catalog NumberNV-L-015G
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerGUNZE LIMITED
Manufacturer Address46 NATSUMEGAICHI, AONO AYABE, KYOTO 623-8513 JA 623-8513


Patients

Patient NumberTreatmentOutcomeDate
151. Life Threatening 2018-07-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.